Key result
Among patients with Type II diabetes mellitus and acute myocardial infarction, short-term mortality was substantial, with 12.0% dying within 1-10 days, 11.7% within 11-20 days, and 13.9% within 21-30 days.
Why the study?
The study was conducted to assess the frequency and short-term survival of acute myocardial infarction patients with diabetes mellitus.
Observational (n=366)
No
Patients with Type II diabetes mellitus presenting with ST elevation myocardial infarction have high short-term mortality rates.
Answers are grounded in this paper and cite their sources.
High short-term mortality in T2DM-AMI signals need for close early monitoring; leaves open targeted intervention trials.
Objective: To assess frequency and survival of AMI patients with diabetes mellitus. Study Type: Prospective observational study. Study Place and Duration: DG Khan Medical College & DHQ Teaching Hospital, DG Khan, from 1st June 2020 to 30th May 2021. Material and methods: The study comprised instances of Type II diabetes mellitus that required admission in the hospital due to ST elevation myocardial infarction and met the other criteria. Electrocardiogram (ECG) 6 hourly, cardiac enzymes on arrival, repeated at two, four, eight, twelve, and twenty four hours, and Troponin T fast assay are among the tests performed. On the basis of the above-mentioned work-up, the definitive diagnosis was made within 48 hours for acute myocardial infarction after admission. The HbA1c level and blood glucose level were also checked to determine the diabetic state. Results: Overall 366 diabetes patients with AMI were studied. Out of these, 269 (73.5%) were males and 97 (26.5%) were females. The mean age of the patients was 44.86±12.26 years. Inferior wall MI was found in (33.3%) patients and left ventricle dysfunction was found in (21.6%) patients. CK-MB and troponin T enzyme was found in raised diabetes patients, (51.9%) and (90.7%), respectively. n=44 (12.0%) deaths were reported in 1-10 days, n=43 (11.7%) deaths were reported in 11-20 days and n=51 (13.9%) deaths were reported in 21-30 days. Conclusion: In current study it was concluded that in patients with diabetes mellitus, the short term mortality increases.
No takes yet. Share an insight, caveat, or question.
Rashid et al. (2022) conducted an observational in Acute Myocardial Infarction with Type II Diabetes Mellitus (n=366). Type II Diabetes Mellitus was evaluated on Short-term mortality (1 to 30 days). Among patients with Type II diabetes mellitus and acute myocardial infarction, short-term mortality was substantial, with 12.0% dying within 1-10 days, 11.7% within 11-20 days, and 13.9% within 21-30 days.
Synapse has enriched 10 related papers. Consider them for comparative context: